-
1
-
-
34548574307
-
Ichthyoses, erythrokeratodermas and related disorders
-
Bolognia JL, Jorizzo JL, Rapini R, eds. St. Louis: Mosby
-
Richard G, Ringpfeil F. Ichthyoses, erythrokeratodermas and related disorders. In: Bolognia JL, Jorizzo JL, Rapini R, eds. Dermatology. St. Louis: Mosby, 2003:775-808.
-
(2003)
Dermatology
, pp. 775-808
-
-
Richard, G.1
Ringpfeil, F.2
-
2
-
-
3242735949
-
Skin lesions in the neonate
-
DOI 10.1016/j.pcl.2004.03.015, PII S0031395504000483
-
Conlon JD, Drolet BA. Skin lesions in the neonate. Pediatr Clin N Am. 2004;51:863-888. (Pubitemid 38962674)
-
(2004)
Pediatric Clinics of North America
, vol.51
, Issue.4
, pp. 863-888
-
-
Conlon, J.D.1
Drolet, B.A.2
-
3
-
-
3042812660
-
Ichthyosiform dermatoses: So many discoveries, so little progress
-
DOI 10.1016/j.jaad.2004.01.019, PII S0190962204002865
-
DiGiovanna, JJ. Ichthyosiform dermatoses: So many discoveries, so little progress. J Am Acad Dermatol. 2004;51:S31-S34. (Pubitemid 38887648)
-
(2004)
Journal of the American Academy of Dermatology
, vol.51
, Issue.1 SUPPL.
-
-
DiGiovanna, J.J.1
-
4
-
-
38949159705
-
Congenital ichthyosis: An overview of current and emerging therapies
-
DOI 10.2340/00015555-0415
-
Vahlquist A, Gånemo A, Virtanen M. Congenital ichthyosis: An overview of current and emerging therapies. Acta Derm Venereol. 2008;88:4-14. (Pubitemid 351212127)
-
(2008)
Acta Dermato-Venereologica
, vol.88
, Issue.1
, pp. 4-14
-
-
Vahlquist, A.1
Ganemo, A.2
Virtanen, M.3
-
5
-
-
0032716344
-
Effect of topical tazarotene in the treatment of congenital ichthyoses
-
DOI 10.1046/j.1365-2133.1999.03101.x
-
Hofmann B, Stege H, Ruzicka T, et al. Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol. 1999;141:642-646. (Pubitemid 29512816)
-
(1999)
British Journal of Dermatology
, vol.141
, Issue.4
, pp. 642-646
-
-
Hofmann, B.1
Stege, H.2
Ruzicka, T.3
Lehmann, P.4
-
6
-
-
0031945968
-
Topical application of tazarotene in the treatment of nonerythrodermic lamellar ichthyosis
-
Stege H, Hofmann B, Ruzicka T, et al. Topical application of tazarotene in the treatment of nonerythrodermic lamellar ichthyosis. Arch Dermatol. 1998;134:640.
-
(1998)
Arch Dermatol
, vol.134
, pp. 640
-
-
Stege, H.1
Hofmann, B.2
Ruzicka, T.3
-
8
-
-
0038045493
-
Type I lamellar ichthyosis improved by tazarotene 0.1% gel
-
DOI 10.1046/j.1365-2230.2003.01318.x
-
Marulli GC, Campione E, Chimenti MS, et al. Type I lamellar ichthyosis improved by tazarotene 0.1% gel. Clin Exp Dermatol. 2003;28:391-393. (Pubitemid 36801845)
-
(2003)
Clinical and Experimental Dermatology
, vol.28
, Issue.4
, pp. 391-393
-
-
Marulli, G.C.1
Campione, E.2
Chimenti, M.S.3
Terrinoni, A.4
Melino, G.5
Bianchi, L.6
-
9
-
-
20444379608
-
Harlequin babies in Puerto Rico
-
Arce SY, Reyes G, Del Carmen Gonzalez M, et al. Harlequin babies in Puerto Rico. Int Pediatr. 2005;20:89-94. (Pubitemid 40807629)
-
(2005)
International Pediatrics
, vol.20
, Issue.2
, pp. 89-94
-
-
Arce, S.Y.1
Reyes, G.2
Del, C.G.M.3
Rabelo, J.4
Valcarcel, M.5
-
10
-
-
0142135949
-
Harlequin Ichthyosis in Association with Hypothyroidism and Juvenile Rheumatoid Arthritis
-
DOI 10.1046/j.1525-1470.2003.20511.x
-
Chan YC, Tay YK, Tan LK, et al. Harlequin ichthyosis in association with hypothyroidism and juvenile rheumatoid arthritis. Pediatr Dermatol. 2003;20:421-426. (Pubitemid 37280488)
-
(2003)
Pediatric Dermatology
, vol.20
, Issue.5
, pp. 421-426
-
-
Chan, Y.-C.1
Tay, Y.-K.2
Tan, L.K.-S.3
Happle, R.4
Giam, Y.-C.5
-
12
-
-
0025904614
-
Retinoic acid receptor gene expression in human skin
-
Elder JT, Fisher GJ, Zhang QY, et al. Retinoic acid receptor gene expression in human skin. J Invest Dermatol. 1991;96:425-433.
-
(1991)
J Invest Dermatol
, vol.96
, pp. 425-433
-
-
Elder, J.T.1
Fisher, G.J.2
Zhang, Q.Y.3
-
13
-
-
10544244166
-
Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: Insight into the mechanism of retinoid action in psoriasis
-
Nagpal S, Thacher SM, Patel S, et al. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: Insight into the mechanism of retinoid action in psoriasis. Cell Growth Differ. 1996;7:1783-1791. (Pubitemid 26415175)
-
(1996)
Cell Growth and Differentiation
, vol.7
, Issue.12
, pp. 1783-1791
-
-
Nagpal, S.1
Thacher, S.M.2
Patel, S.3
Friant, S.4
Malhotra, M.5
Shafer, J.6
Krasinski, G.7
Asano, A.T.8
Teng, M.9
Duvic, M.10
Chandraratna, R.A.S.11
-
14
-
-
0028209742
-
Response of psoriasis to a new topical retinoid, AGN 190168
-
Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, et al. Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol. 1994;30:581-590. (Pubitemid 24121758)
-
(1994)
Journal of the American Academy of Dermatology
, vol.30
, Issue.4
, pp. 581-590
-
-
Esgleyes-Ribot, T.1
Chandraratna, R.A.2
Lew-Kaya, D.A.3
Sefton, J.4
Duvic, M.5
-
15
-
-
0030847171
-
Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin
-
Nagpal S, Patel S, Jacobe H, et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol. 1997;109:91-95. (Pubitemid 27305655)
-
(1997)
Journal of Investigative Dermatology
, vol.109
, Issue.1
, pp. 91-95
-
-
Nagpal, S.1
Patel, S.2
Jacobe, H.3
DiSepio, D.4
Ghosn, C.5
Malhotra, M.6
Teng, M.7
Duvic, M.8
Chandraratna, R.A.S.9
-
16
-
-
0029912543
-
Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin
-
Nagpal S, Patel S, Asano AT, et al. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol. 1996;106:269-274. (Pubitemid 26096423)
-
(1996)
Journal of Investigative Dermatology
, vol.106
, Issue.2
, pp. 269-274
-
-
Nagpal, S.1
Patel, S.2
Asano, A.T.3
Johnson, A.T.4
Duvic, M.5
Chandraratna, R.A.S.6
-
17
-
-
35248854984
-
Treatment of ichthyosiform diseases with topically applied tazarotene: Risk of systemic absorption
-
DOI 10.1016/j.jaad.2006.05.028, PII S0190962206015003
-
Nguyen V, Cunningham BB, Eichenfield LF, et al. Treatment of ichthyosiform diseases with topically applied tazarotene: Risk of systemic absorption. J Am Acad Dermatol. 2007;57:S123-S125. (Pubitemid 47559095)
-
(2007)
Journal of the American Academy of Dermatology
, vol.57
, Issue.5 SUPPL.
-
-
Nguyen, V.1
Cunningham, B.B.2
Eichenfield, L.F.3
Alio, A.B.4
Buka, R.L.5
-
18
-
-
0029827538
-
Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis
-
Weinstein GD. Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis. Br J Dermatol. 1996;135:32-36. (Pubitemid 26343207)
-
(1996)
British Journal of Dermatology, Supplement
, vol.135
, Issue.49
, pp. 32-36
-
-
Weinstein, G.D.1
|